Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s diseaseShinji Saiki, Nobutaka Hattori, Takahiro Koinuma et al.|Scientific Reports|2017Cited by 143
A metabolic profile of polyamines in parkinson disease: A promising biomarkerShinji Saiki, Nobutaka Hattori, Yukiko Sasazawa et al.|Annals of Neurology|2019Cited by 123
Variants in saposin D domain of prosaposin gene linked to Parkinson’s diseaseYutaka Oji, Nobutaka Hattori, Taku Hatano et al.|Brain|2020Cited by 120
Serum caffeine and metabolites are reliable biomarkers of early Parkinson diseaseMotoki Fujimaki, Nobutaka Hattori, Shinji Saiki et al.|Neurology|2018Cited by 103